Aarti Drugs

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE767A01016
  • NSEID: AARTIDRUGS
  • BSEID: 524348
INR
393.40
9.95 (2.59%)
BSENSE

Feb 03

BSE+NSE Vol: 2.73 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 657348,
    "name": "Aarti Drugs",
    "stock_name": "Aarti Drugs",
    "full_name": "Aarti Drugs Ltd",
    "name_url": "stocks-analysis/aarti-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "393.40",
    "chg": 9.95,
    "chgp": "2.59%",
    "dir": 1,
    "prev_price": "383.45",
    "mcapval": "3,602.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524348,
    "symbol": "AARTIDRUGS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE767A01016",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "2.73 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aarti-drugs-657348-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Aarti Drugs Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-aarti-drugs-ltd-latest-results-good-or-bad-3818954",
        "imagepath": "",
        "date": "2026-02-03 19:18:21",
        "description": "Aarti Drugs Ltd's latest financial results for Q2 FY26 reveal a mixed performance characterized by significant year-on-year growth in net sales and net profit, alongside sequential challenges in profitability. The company reported net sales of ₹652.79 crores, reflecting a quarter-on-quarter growth of 10.55% and a year-on-year increase of 9.10%. This growth underscores Aarti Drugs' ability to expand its topline, driven by strong demand across its product portfolios, particularly in antibiotics, anti-inflammatory, and anti-diabetic segments.\n\nHowever, the net profit for the quarter stood at ₹45.28 crores, which indicates a decline of 16.01% compared to the previous quarter, despite a notable year-on-year increase of 29.33%. This sequential decline raises questions regarding the sustainability of profitability, particularly as the PAT margin contracted to 6.92%, down from 9.14% in the prior quarter. The operat..."
      },
      {
        "title": "Aarti Drugs Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-drugs-ltd-is-rated-sell-3813987",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AartiDrugsLtd_mojoScore_3813987.png",
        "date": "2026-02-01 10:10:56",
        "description": "Aarti Drugs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 February 2026, providing investors with the most recent and relevant data to assess the company’s outlook."
      },
      {
        "title": "When is the next results date for Aarti Drugs Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-aarti-drugs-ltd-3808359",
        "imagepath": "",
        "date": "2026-01-28 23:16:16",
        "description": "The next results date for Aarti Drugs Ltd is scheduled for February 3, 2026...."
      },
      {
        "title": "Aarti Drugs Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-drugs-ltd-is-rated-sell-3798102",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AartiDrugsLtd_mojoScore_3798102.png",
        "date": "2026-01-21 10:10:53",
        "description": "Aarti Drugs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 07 January 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 21 January 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Aarti Drugs Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-drugs-ltd-is-rated-sell-3787929",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AartiDrugsLtd_mojoScore_3787929.png",
        "date": "2026-01-10 10:10:49",
        "description": "Aarti Drugs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 10 January 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Why is Aarti Drugs Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-aarti-drugs-ltd-fallingrising-3786006",
        "imagepath": "",
        "date": "2026-01-09 02:28:59",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Performance</strong></p>\n<p>The stock has been on a downward trajectory over the past week, falling by 6.17%, significantly underperforming the Sensex’s modest decline of 1.18% during the same period. Year-to-date, Aarti Drugs has lost 5.10%, while the benchmark index has only dipped by 1.22%. Over the last year, the stock’s return stands at a negative 12.77%, contrasting sharply with the Sensex’s positive 7.72% gain. This trend extends over longer horizons, with the stock delivering a 46.86% loss over five years, whereas the Sensex has appreciated by 72.56% in that timeframe.</p>\n<p>On the day of the decline, the stock underperformed its sector by 1.88%, touching an intraday low of ₹390.10, down 3.49%. The weighted average price indicates that more volume wa..."
      },
      {
        "title": "Aarti Drugs Ltd Technical Momentum Shifts Amid Bearish Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-drugs-ltd-technical-momentum-shifts-amid-bearish-signals-3780913",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AartiDrugsLtd_technicaldot_3780913.png",
        "date": "2026-01-05 08:05:03",
        "description": "Aarti Drugs Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend despite some mildly bullish monthly signals. The stock’s recent downgrade from a Sell to a Hold rating reflects this evolving technical landscape, underscoring the challenges faced by the pharmaceutical company amid broader market dynamics."
      },
      {
        "title": "Aarti Drugs Ltd Declines 1.28% Amid Technical Sell-Off and Mixed Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-drugs-ltd-declines-128-amid-technical-sell-off-and-mixed-signals-3779802",
        "imagepath": "",
        "date": "2026-01-04 09:48:00",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>29 Dec 2025:</strong> Downgrade to Sell by MarketsMOJO citing technical and growth concerns</p>\n                    <p><strong>29 Dec 2025:</strong> Technical momentum shifts to bearish with negative daily price movement</p>\n                    <p><strong>30 Dec 2025:</strong> Mixed technical signals amid continued bearish sentiment</p>\n                    <p><strong>2 Jan 2026:</strong> Week closes at ₹411.20, down 1.28% despite Sensex gains</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.416.55</div></div>\n                    <div class=\"stat-item\"><di..."
      },
      {
        "title": "Aarti Drugs Ltd Technical Momentum Shifts Amid Bearish Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-drugs-ltd-technical-momentum-shifts-amid-bearish-sentiment-3774200",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AartiDrugsLtd_technicaldot_3774200.png",
        "date": "2025-12-30 08:12:05",
        "description": "Aarti Drugs Ltd has experienced a notable shift in its technical momentum, reflecting a transition from bearish to mildly bearish trends across key indicators. Despite a recent downgrade to a Sell rating by MarketsMOJO, the stock’s mixed technical signals and price action warrant a detailed analysis for investors navigating the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 660,
    "sid": "657348",
    "stock_news_url": "https://www.marketsmojo.com/news/aarti-drugs-657348"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
      "datetime": "29-Jan-2026",
      "details": "Credit rating",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "28-Jan-2026",
      "details": "Intimation of Quarterly Earning Conference Call for Q3 FY26",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Audited Financial Results For The Quarter And Nine Months Ended December 31 2025 And Interim Dividend For The FY 2025-26 If Any",
      "datetime": "27-Jan-2026",
      "details": "Aarti Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 inter alia to consider and approve Audited financial results for the quarter and nine months ended December 31 2025 and Interim Dividend for the FY 2025-26 if any",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "(03 Feb 2026)"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aarti Drugs Ltd has declared <strong>10%</strong> dividend, ex-date: 04 Feb 25",
          "dt": "2025-02-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Aarti Drugs Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 30 Sep 20",
          "dt": "2020-09-30",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Why is Aarti Drugs Ltd falling/rising?

2026-01-09 02:28:59

Recent Price Movement and Market Performance

The stock has been on a downward trajectory over the past week, falling by 6.17%, significantly underperforming the Sensex’s modest decline of 1.18% during the same period. Year-to-date, Aarti Drugs has lost 5.10%, while the benchmark index has only dipped by 1.22%. Over the last year, the stock’s return stands at a negative 12.77%, contrasting sharply with the Sensex’s positive 7.72% gain. This trend extends over longer horizons, with the stock delivering a 46.86% loss over five years, whereas the Sensex has appreciated by 72.56% in that timeframe.

On the day of the decline, the stock underperformed its sector by 1.88%, touching an intraday low of ₹390.10, down 3.49%. The weighted average price indicates that more volume wa...

Read full news article
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Credit Rating

29-Jan-2026 | Source : BSE

Credit rating

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

28-Jan-2026 | Source : BSE

Intimation of Quarterly Earning Conference Call for Q3 FY26

Board Meeting Intimation for Audited Financial Results For The Quarter And Nine Months Ended December 31 2025 And Interim Dividend For The FY 2025-26 If Any

27-Jan-2026 | Source : BSE

Aarti Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 inter alia to consider and approve Audited financial results for the quarter and nine months ended December 31 2025 and Interim Dividend for the FY 2025-26 if any

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

(03 Feb 2026)

stock-summary
DIVIDEND

Aarti Drugs Ltd has declared 10% dividend, ex-date: 04 Feb 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Aarti Drugs Ltd has announced 3:1 bonus issue, ex-date: 30 Sep 20

stock-summary
RIGHTS

No Rights history available